Mohammed AlOraini Appointed as Senior Associate – Rare Disease at Amgen

Mohammed AlOraini, CMSL® has been appointed as Senior Associate – Rare Disease at Amgen, marking a significant step forward in his journey within the pharmaceutical and healthcare sector.

With a strong background across Amgen, Bayer, and Hikma Pharmaceuticals, he brings valuable experience in patient access, stakeholder engagement, and therapy promotion, particularly in specialized and underserved areas.

In his new role, he will focus on supporting rare disease therapies, strengthening collaborations with healthcare stakeholders, and driving patient-centric initiatives to improve access and outcomes.